recent articles
We’re proud to share that Deciphex and Diagnexia have been recognised at the Pharma Industry Awards UK 2025! 🏆 Best Use of Technology Award – Diagnexia & East Sussex Healthcare NHS Trust 🏆 Partnership Alliance of the Year –...
From Diagnexia on LinkedIn We’re excited to announce that Diagnexia will be attending ADLM 2025! Date: July 27-31 Location: Chicago, IL Stop by booth 4731 to learn how our network of state-licensed, subspecialty-trained pathologists...
A case study from Diagnexia The global shortage of pathologists has posed significant challenges for healthcare providers, increasing workloads, leading to backlogs, and delaying critical diagnoses. To address these challenges, East...
Diagnexia and Stratipath: Collaboration expands AI-based risk profiling tools Diagnexia has announced a partnership with Stratipath AB to bring Stratipath Breast, an AI-based prognostic risk profiling tool, to healthcare providers...
Naperville, IL, USA, 28th January 2025 – Diagnexia announces the launch of its enterprise-grade digital pathology platform that seamlessly connects US laboratories to its broad network of board-certified sub-specialty pathologists. Built for...
United Kingdom – Diagnexia UK Limited is delighted to announce its recent accreditation to ISO 15189:2022 for their digital pathology service, a globally recognised standard for medical laboratory requirements for quality and competence....